Briefs

THE MARKET FOR DATA ANALYSIS APPLICATIONS IN BIOPHARMACEUTICAL
RESEARCH WILL GROWTH TO $20.45 MILLION BY 2008 SAYS SILICO RESEARCH

LONDON 19TH APRIL, 2001 Research by Silico Research concludes that the
market for data analytics (statistical, data mining and visualisation)
software in pharmaceutical research and development process is $17.40
million. This excludes data, hardware and services.

"We expect the market to grow by 17% over the next eight years to
$20.45 million as growth in the user base and online access is
balanced by increased competition, more bundling by major vendors and
falling application prices" said Emmett Power, Chief Executive Officer
of Silico Research and lead analyst on the research.

He went on to say "The number of potential users of data analysis
applications in the biopharmaceutical research sector, chemists,
biologists, statisticians and mathematicians in developed economies
will grow from 63,000 in 2000 to 72,000 in 2008. The fastest growth
will be seen amongst biological scientists where we expect to see the
number employed grow by nearly 3% a year to 21,700 in 2008. This will
act as a cap the potential growth in the data analysis applications
space."

According to the study the growth of scientists employed by
biopharmaceutical companies in developed economies will be linked to
the growth of employment in scientific operations in India and
China. This will, in turn, be linked to the resolution of the
intellectual property issues currently being addressed by
biopharmaceutical companies in South Africa and other developing
economies.

The strongest growth in demand for data analytical applications will
be in visualisation applications targeted at early stage discovery
applications.

"We expect to see slower growth in statistical applications and
applications designed to analyse clinical trials data. The most
important drivers of the market will be the growth in genomic and
proteomic data, online access and the drive to integrate data from
clinical trials into drug discovery and development processes"
continued Emmett Power.

The market is dominated by SAS, SPSS and SGI. These three companies
together have a market share of just under 57%. Another 30 companies
fight for the remaining market share with an array of business models.

Silico Research expects the major database vendors, IBM, Oracle and
Microsoft to become a significant presence in the market over the next
five years as they increasingly package analytical software with
database, data warehouse and data integration products.

The viability of smaller vendors will be tied to their ability to lock
into revenue streams from data and consultancy services or to link
with a major company in the sector.

Silico Research is a leading independent research and consulting
organisation, analysing technological change and its impact on the
pharmaceutical, biotechnology and life science sectors. Silico
Research's clients receive continuous research and analysis through
Silico's customized continuous advisory services. Silico's Research
Centre is located in London.

An Executive Summary of the Research Report and additional information
about Silico Research can be found at www.Silico-Research.com.